Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients

BackgroundDespite improvements in overall survival, the recurrence of differentiated thyroid cancer (DTC) is becoming more common and remains a challenge necessitating accurate reappraisal of the patient. This study aimed to describe the characteristics, reasons, morbidity, and strategies of second...

Full description

Bibliographic Details
Main Authors: Nan Liang, Han Zhang, Chengqiu Sui, Rui Du, Canxiao Li, Jingting Li, Gianlorenzo Dionigi, Daqi Zhang, Hui Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1301620/full
_version_ 1797403233326465024
author Nan Liang
Han Zhang
Chengqiu Sui
Rui Du
Canxiao Li
Jingting Li
Gianlorenzo Dionigi
Daqi Zhang
Hui Sun
author_facet Nan Liang
Han Zhang
Chengqiu Sui
Rui Du
Canxiao Li
Jingting Li
Gianlorenzo Dionigi
Daqi Zhang
Hui Sun
author_sort Nan Liang
collection DOAJ
description BackgroundDespite improvements in overall survival, the recurrence of differentiated thyroid cancer (DTC) is becoming more common and remains a challenge necessitating accurate reappraisal of the patient. This study aimed to describe the characteristics, reasons, morbidity, and strategies of second operations for DTC.MethodsThis was a retrospective observational study of patients with DTC who underwent a second surgery between June 2008 and June 2021 in the Department of Thyroid Surgery at China–Japanese Union Hospital, Jilin University, P.R. China. All clinical characteristics were recorded, and the analysis was estimated using SPSS.ResultsSecond surgeries were detected in 683 patients. The proportion of second operations changed with the update of international guidelines from 2015 (P < 0.001). The true recurrence rate progressively increased from 21.3% to 61.5%. The rate of an “absence of preoperative FNA” or an “absence of intraoperative pathology at first surgery” decreased from 49.8% to 12.7%, while that of a “misdiagnosis of preoperative FNA at second surgery” decreased from 10% to 1.8%. The most common tumor location during the second surgery was the lateral lymph nodes (n = 104, 36.5%), with a median time to relapse of 36 months. Completion of thyroidectomy and lymph node dissection correlated with the second operation.ConclusionAfter 2015, second surgeries were more standardized, the incidence of complications decreased, and real recurrence became the most common reason for a second DTC surgery.
first_indexed 2024-03-09T02:35:36Z
format Article
id doaj.art-8c93f8c0af334fe0a1a34680e1bb39b8
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-09T02:35:36Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-8c93f8c0af334fe0a1a34680e1bb39b82023-12-06T08:35:21ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-12-011410.3389/fendo.2023.13016201301620Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patientsNan Liang0Han Zhang1Chengqiu Sui2Rui Du3Canxiao Li4Jingting Li5Gianlorenzo Dionigi6Daqi Zhang7Hui Sun8Division of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, ChinaDivision of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDivision of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, ChinaDivision of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, ChinaDivision of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, ChinaDivision of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, ChinaDepartment of Medical Biotechnology and Translational Medicine, Division of General and Endocrine Surgery, Istituto Auxologico Italiano IRCCS, University of Milan, Milan, ItalyDivision of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, ChinaDivision of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, ChinaBackgroundDespite improvements in overall survival, the recurrence of differentiated thyroid cancer (DTC) is becoming more common and remains a challenge necessitating accurate reappraisal of the patient. This study aimed to describe the characteristics, reasons, morbidity, and strategies of second operations for DTC.MethodsThis was a retrospective observational study of patients with DTC who underwent a second surgery between June 2008 and June 2021 in the Department of Thyroid Surgery at China–Japanese Union Hospital, Jilin University, P.R. China. All clinical characteristics were recorded, and the analysis was estimated using SPSS.ResultsSecond surgeries were detected in 683 patients. The proportion of second operations changed with the update of international guidelines from 2015 (P < 0.001). The true recurrence rate progressively increased from 21.3% to 61.5%. The rate of an “absence of preoperative FNA” or an “absence of intraoperative pathology at first surgery” decreased from 49.8% to 12.7%, while that of a “misdiagnosis of preoperative FNA at second surgery” decreased from 10% to 1.8%. The most common tumor location during the second surgery was the lateral lymph nodes (n = 104, 36.5%), with a median time to relapse of 36 months. Completion of thyroidectomy and lymph node dissection correlated with the second operation.ConclusionAfter 2015, second surgeries were more standardized, the incidence of complications decreased, and real recurrence became the most common reason for a second DTC surgery.https://www.frontiersin.org/articles/10.3389/fendo.2023.1301620/fullthyroid cancerrecurrencesurgerymorbiditysecond surgery
spellingShingle Nan Liang
Han Zhang
Chengqiu Sui
Rui Du
Canxiao Li
Jingting Li
Gianlorenzo Dionigi
Daqi Zhang
Hui Sun
Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients
Frontiers in Endocrinology
thyroid cancer
recurrence
surgery
morbidity
second surgery
title Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients
title_full Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients
title_fullStr Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients
title_full_unstemmed Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients
title_short Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients
title_sort surgical resection of recurrent differentiated thyroid cancer patterns detection staging and treatment of 683 patients
topic thyroid cancer
recurrence
surgery
morbidity
second surgery
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1301620/full
work_keys_str_mv AT nanliang surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT hanzhang surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT chengqiusui surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT ruidu surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT canxiaoli surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT jingtingli surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT gianlorenzodionigi surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT daqizhang surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients
AT huisun surgicalresectionofrecurrentdifferentiatedthyroidcancerpatternsdetectionstagingandtreatmentof683patients